Loading…

New molecular insights for 4 H -1,2,4-triazole derivatives as inhibitors of tankyrase and Wnt-signaling antagonist: a molecular dynamics simulation study

Tankyrase (TNKS) enzymes remained central biotargets to treat Wnt-driven colorectal cancers. The success of Olaparib posited the druggability of PARP family enzymes depending on their role in tumor proliferation. In this work, an MD-simulation-based comparative assessment of the protein-ligand inter...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biomolecular structure & dynamics 2023-12, Vol.41 (22), p.1-13508
Main Authors: Mehta, Chirag C, Rohit, Shishir, Patel, Saumya, Bhatt, Hardik G
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c698-b986d3b47db10eb2fac2e0ae230129750cbdb44e156fd79bfd984f751f83bf1c3
container_end_page 13508
container_issue 22
container_start_page 1
container_title Journal of biomolecular structure & dynamics
container_volume 41
creator Mehta, Chirag C
Rohit, Shishir
Patel, Saumya
Bhatt, Hardik G
description Tankyrase (TNKS) enzymes remained central biotargets to treat Wnt-driven colorectal cancers. The success of Olaparib posited the druggability of PARP family enzymes depending on their role in tumor proliferation. In this work, an MD-simulation-based comparative assessment of the protein-ligand interactions using the best-docked poses of three selected compounds (two of the designed and previously synthesized molecules obtained through molecular docking and one reported TNKS inhibitor) was performed for a 500 ns period. The PDB:ID-7KKP and 3U9H were selected for TNKS1 and TNKS2, respectively. The Molecular Mechanics Generalized Born Surface Area (MM-GBSA) based binding energy data exhibited stronger binding of compound-15 (average values of -102.92 and -104.32 kcal/mol for TNKS1 and TNKS2, respectively) as compared to compound-22 (average values of -82.99 and -85.68 kcal/mol for TNKS1 and TNKS2, respectively) and the reported compound-32 (average values of -81.89 and -74.43 kcal/mol for TNKS1 and TNKS2, respectively). Compound-15 and compound-22 exhibited comparable or superior binding to both receptors forming stable complexes when compared to that of compound-32 upon examining their MD trajectories. The key contributors were hydrophobic stacking and optimum hydrogen bonding allowing these molecules to occupy the adenosine pocket by interfacing D-loop residues. The results of bond distance analysis, radius of gyration, root mean square deviation, root mean square fluctuation, snapshots at different time intervals, LUMO-HUMO energy differences, electrostatic potential calculations, and binding free energy suggested better binding efficiency for compound-15 to TNKS enzymes. The computed physicochemical and ADMET properties of compound-15 were encouraging and could be explored further for drug development.Communicated by Ramaswamy H. Sarma.
doi_str_mv 10.1080/07391102.2023.2175376
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1080_07391102_2023_2175376</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>36755438</sourcerecordid><originalsourceid>FETCH-LOGICAL-c698-b986d3b47db10eb2fac2e0ae230129750cbdb44e156fd79bfd984f751f83bf1c3</originalsourceid><addsrcrecordid>eNpNkN1KwzAYhoMobk4vQckFrDM_TdN6JkOdMPRk4GFJmmSLtulIskm9E-_Wljnx6IOX530_eAC4xmiGUY5uEacFxojMCCJ0RjBnlGcnYIwZzRNEWHoKxgOTDNAIXITwjhDBmONzMKIZZyyl-Rh8v-hP2LS1rna18NC6YNebGKBpPUzhAiZ4SqZpEr0VXz0FlfZ2L6Ld6wBF6PmNlTa2PsDWwCjcR-dF0FA4Bd9cTPo1J2rr1n0Sxbp1NsQ7KP59VJ0Tja0CDLbpg2hbB0Pcqe4SnBlRB331eydg9fiwmi-S5evT8_x-mVRZkSeyyDNFZcqVxEhLYkRFNBKaUIRJwRmqpJJpqjHLjOKFNKrIU8MZNjmVBld0AthhtvJtCF6bcuttI3xXYlQOpsuj6XIwXf6a7ns3h952Jxut_lpHtfQHbzV8WA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>New molecular insights for 4 H -1,2,4-triazole derivatives as inhibitors of tankyrase and Wnt-signaling antagonist: a molecular dynamics simulation study</title><source>Taylor and Francis Science and Technology Collection</source><creator>Mehta, Chirag C ; Rohit, Shishir ; Patel, Saumya ; Bhatt, Hardik G</creator><creatorcontrib>Mehta, Chirag C ; Rohit, Shishir ; Patel, Saumya ; Bhatt, Hardik G</creatorcontrib><description>Tankyrase (TNKS) enzymes remained central biotargets to treat Wnt-driven colorectal cancers. The success of Olaparib posited the druggability of PARP family enzymes depending on their role in tumor proliferation. In this work, an MD-simulation-based comparative assessment of the protein-ligand interactions using the best-docked poses of three selected compounds (two of the designed and previously synthesized molecules obtained through molecular docking and one reported TNKS inhibitor) was performed for a 500 ns period. The PDB:ID-7KKP and 3U9H were selected for TNKS1 and TNKS2, respectively. The Molecular Mechanics Generalized Born Surface Area (MM-GBSA) based binding energy data exhibited stronger binding of compound-15 (average values of -102.92 and -104.32 kcal/mol for TNKS1 and TNKS2, respectively) as compared to compound-22 (average values of -82.99 and -85.68 kcal/mol for TNKS1 and TNKS2, respectively) and the reported compound-32 (average values of -81.89 and -74.43 kcal/mol for TNKS1 and TNKS2, respectively). Compound-15 and compound-22 exhibited comparable or superior binding to both receptors forming stable complexes when compared to that of compound-32 upon examining their MD trajectories. The key contributors were hydrophobic stacking and optimum hydrogen bonding allowing these molecules to occupy the adenosine pocket by interfacing D-loop residues. The results of bond distance analysis, radius of gyration, root mean square deviation, root mean square fluctuation, snapshots at different time intervals, LUMO-HUMO energy differences, electrostatic potential calculations, and binding free energy suggested better binding efficiency for compound-15 to TNKS enzymes. The computed physicochemical and ADMET properties of compound-15 were encouraging and could be explored further for drug development.Communicated by Ramaswamy H. Sarma.</description><identifier>ISSN: 0739-1102</identifier><identifier>EISSN: 1538-0254</identifier><identifier>DOI: 10.1080/07391102.2023.2175376</identifier><identifier>PMID: 36755438</identifier><language>eng</language><publisher>England</publisher><ispartof>Journal of biomolecular structure &amp; dynamics, 2023-12, Vol.41 (22), p.1-13508</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c698-b986d3b47db10eb2fac2e0ae230129750cbdb44e156fd79bfd984f751f83bf1c3</cites><orcidid>0000-0003-4688-414X ; 0000-0003-4919-1322 ; 0000-0002-6431-0695 ; 0000-0003-0932-5613</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36755438$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mehta, Chirag C</creatorcontrib><creatorcontrib>Rohit, Shishir</creatorcontrib><creatorcontrib>Patel, Saumya</creatorcontrib><creatorcontrib>Bhatt, Hardik G</creatorcontrib><title>New molecular insights for 4 H -1,2,4-triazole derivatives as inhibitors of tankyrase and Wnt-signaling antagonist: a molecular dynamics simulation study</title><title>Journal of biomolecular structure &amp; dynamics</title><addtitle>J Biomol Struct Dyn</addtitle><description>Tankyrase (TNKS) enzymes remained central biotargets to treat Wnt-driven colorectal cancers. The success of Olaparib posited the druggability of PARP family enzymes depending on their role in tumor proliferation. In this work, an MD-simulation-based comparative assessment of the protein-ligand interactions using the best-docked poses of three selected compounds (two of the designed and previously synthesized molecules obtained through molecular docking and one reported TNKS inhibitor) was performed for a 500 ns period. The PDB:ID-7KKP and 3U9H were selected for TNKS1 and TNKS2, respectively. The Molecular Mechanics Generalized Born Surface Area (MM-GBSA) based binding energy data exhibited stronger binding of compound-15 (average values of -102.92 and -104.32 kcal/mol for TNKS1 and TNKS2, respectively) as compared to compound-22 (average values of -82.99 and -85.68 kcal/mol for TNKS1 and TNKS2, respectively) and the reported compound-32 (average values of -81.89 and -74.43 kcal/mol for TNKS1 and TNKS2, respectively). Compound-15 and compound-22 exhibited comparable or superior binding to both receptors forming stable complexes when compared to that of compound-32 upon examining their MD trajectories. The key contributors were hydrophobic stacking and optimum hydrogen bonding allowing these molecules to occupy the adenosine pocket by interfacing D-loop residues. The results of bond distance analysis, radius of gyration, root mean square deviation, root mean square fluctuation, snapshots at different time intervals, LUMO-HUMO energy differences, electrostatic potential calculations, and binding free energy suggested better binding efficiency for compound-15 to TNKS enzymes. The computed physicochemical and ADMET properties of compound-15 were encouraging and could be explored further for drug development.Communicated by Ramaswamy H. Sarma.</description><issn>0739-1102</issn><issn>1538-0254</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpNkN1KwzAYhoMobk4vQckFrDM_TdN6JkOdMPRk4GFJmmSLtulIskm9E-_Wljnx6IOX530_eAC4xmiGUY5uEacFxojMCCJ0RjBnlGcnYIwZzRNEWHoKxgOTDNAIXITwjhDBmONzMKIZZyyl-Rh8v-hP2LS1rna18NC6YNebGKBpPUzhAiZ4SqZpEr0VXz0FlfZ2L6Ld6wBF6PmNlTa2PsDWwCjcR-dF0FA4Bd9cTPo1J2rr1n0Sxbp1NsQ7KP59VJ0Tja0CDLbpg2hbB0Pcqe4SnBlRB331eydg9fiwmi-S5evT8_x-mVRZkSeyyDNFZcqVxEhLYkRFNBKaUIRJwRmqpJJpqjHLjOKFNKrIU8MZNjmVBld0AthhtvJtCF6bcuttI3xXYlQOpsuj6XIwXf6a7ns3h952Jxut_lpHtfQHbzV8WA</recordid><startdate>20231229</startdate><enddate>20231229</enddate><creator>Mehta, Chirag C</creator><creator>Rohit, Shishir</creator><creator>Patel, Saumya</creator><creator>Bhatt, Hardik G</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0003-4688-414X</orcidid><orcidid>https://orcid.org/0000-0003-4919-1322</orcidid><orcidid>https://orcid.org/0000-0002-6431-0695</orcidid><orcidid>https://orcid.org/0000-0003-0932-5613</orcidid></search><sort><creationdate>20231229</creationdate><title>New molecular insights for 4 H -1,2,4-triazole derivatives as inhibitors of tankyrase and Wnt-signaling antagonist: a molecular dynamics simulation study</title><author>Mehta, Chirag C ; Rohit, Shishir ; Patel, Saumya ; Bhatt, Hardik G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c698-b986d3b47db10eb2fac2e0ae230129750cbdb44e156fd79bfd984f751f83bf1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mehta, Chirag C</creatorcontrib><creatorcontrib>Rohit, Shishir</creatorcontrib><creatorcontrib>Patel, Saumya</creatorcontrib><creatorcontrib>Bhatt, Hardik G</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of biomolecular structure &amp; dynamics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mehta, Chirag C</au><au>Rohit, Shishir</au><au>Patel, Saumya</au><au>Bhatt, Hardik G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>New molecular insights for 4 H -1,2,4-triazole derivatives as inhibitors of tankyrase and Wnt-signaling antagonist: a molecular dynamics simulation study</atitle><jtitle>Journal of biomolecular structure &amp; dynamics</jtitle><addtitle>J Biomol Struct Dyn</addtitle><date>2023-12-29</date><risdate>2023</risdate><volume>41</volume><issue>22</issue><spage>1</spage><epage>13508</epage><pages>1-13508</pages><issn>0739-1102</issn><eissn>1538-0254</eissn><abstract>Tankyrase (TNKS) enzymes remained central biotargets to treat Wnt-driven colorectal cancers. The success of Olaparib posited the druggability of PARP family enzymes depending on their role in tumor proliferation. In this work, an MD-simulation-based comparative assessment of the protein-ligand interactions using the best-docked poses of three selected compounds (two of the designed and previously synthesized molecules obtained through molecular docking and one reported TNKS inhibitor) was performed for a 500 ns period. The PDB:ID-7KKP and 3U9H were selected for TNKS1 and TNKS2, respectively. The Molecular Mechanics Generalized Born Surface Area (MM-GBSA) based binding energy data exhibited stronger binding of compound-15 (average values of -102.92 and -104.32 kcal/mol for TNKS1 and TNKS2, respectively) as compared to compound-22 (average values of -82.99 and -85.68 kcal/mol for TNKS1 and TNKS2, respectively) and the reported compound-32 (average values of -81.89 and -74.43 kcal/mol for TNKS1 and TNKS2, respectively). Compound-15 and compound-22 exhibited comparable or superior binding to both receptors forming stable complexes when compared to that of compound-32 upon examining their MD trajectories. The key contributors were hydrophobic stacking and optimum hydrogen bonding allowing these molecules to occupy the adenosine pocket by interfacing D-loop residues. The results of bond distance analysis, radius of gyration, root mean square deviation, root mean square fluctuation, snapshots at different time intervals, LUMO-HUMO energy differences, electrostatic potential calculations, and binding free energy suggested better binding efficiency for compound-15 to TNKS enzymes. The computed physicochemical and ADMET properties of compound-15 were encouraging and could be explored further for drug development.Communicated by Ramaswamy H. Sarma.</abstract><cop>England</cop><pmid>36755438</pmid><doi>10.1080/07391102.2023.2175376</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0003-4688-414X</orcidid><orcidid>https://orcid.org/0000-0003-4919-1322</orcidid><orcidid>https://orcid.org/0000-0002-6431-0695</orcidid><orcidid>https://orcid.org/0000-0003-0932-5613</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0739-1102
ispartof Journal of biomolecular structure & dynamics, 2023-12, Vol.41 (22), p.1-13508
issn 0739-1102
1538-0254
language eng
recordid cdi_crossref_primary_10_1080_07391102_2023_2175376
source Taylor and Francis Science and Technology Collection
title New molecular insights for 4 H -1,2,4-triazole derivatives as inhibitors of tankyrase and Wnt-signaling antagonist: a molecular dynamics simulation study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T00%3A39%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=New%20molecular%20insights%20for%204%20H%20-1,2,4-triazole%20derivatives%20as%20inhibitors%20of%20tankyrase%20and%20Wnt-signaling%20antagonist:%20a%20molecular%20dynamics%20simulation%20study&rft.jtitle=Journal%20of%20biomolecular%20structure%20&%20dynamics&rft.au=Mehta,%20Chirag%20C&rft.date=2023-12-29&rft.volume=41&rft.issue=22&rft.spage=1&rft.epage=13508&rft.pages=1-13508&rft.issn=0739-1102&rft.eissn=1538-0254&rft_id=info:doi/10.1080/07391102.2023.2175376&rft_dat=%3Cpubmed_cross%3E36755438%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c698-b986d3b47db10eb2fac2e0ae230129750cbdb44e156fd79bfd984f751f83bf1c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/36755438&rfr_iscdi=true